US Patent Litigations are now available. Check here

Explore Acceleron Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3490582Jun 12, 2024Methods And Compositions For Treating Myelofibrosis2
EP3226887Mar 27, 2024Methods For Treating Myelodysplastic Syndromes And Sideroblastic Anemias1
EP3380121Dec 20, 2023Methods For Treating Eye Disorders1